Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/EJA.0000000000001163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
Ann Surg Oncol
August 2024
Margaret West Comprehensive Breast Center, West Cancer Center, Germantown, TN, USA.
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.
Eur J Cancer
May 2024
Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Background And Aim: Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer with highly variable clinical behavior, but risk stratification is still challenging. We sought to identify immune-related gene expression signatures of pure DCIS associated with different risks of breast cancer recurrence.
Methods: A retrospective nested case-control study of 143 pure DCIS was performed including 70 women with subsequent ipsilateral breast event (IBE, in situ or invasive; cases) and 73 DCIS women with no IBE and matched for age, tumor size, treatment, hormone receptors/HER2 status, and follow-up time (controls).
Ipsilateral Upper-Limb Lymphedema After COVID-19 Vaccine Booster: Reply.
Clin Nucl Med
September 2023
Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!